Choreo LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Buy
142,648
+3,169
+2% +$738K 0.43% 45
2025
Q4
$28.9M Sell
139,479
-2,243
-2% -$444K 0.37% 47
2025
Q3
$26.3M Buy
141,722
+1,901
+1% +$326K 0.34% 52
2025
Q2
$21.4M Buy
139,821
+5,416
+4% +$833K 0.3% 61
2025
Q1
$22.3M Buy
134,405
+4,825
+4% +$755K 0.35% 58
2024
Q4
$18.6M Buy
129,580
+14,619
+13% +$2.27M 0.27% 75
2024
Q3
$18.6M Buy
114,961
+5,170
+5% +$824K 0.27% 72
2024
Q2
$16.1M Buy
109,791
+56,511
+106% +$8.4M 0.27% 73
2024
Q1
$8.43M Sell
53,280
-1,367
-3% -$218K 0.22% 71
2023
Q4
$8.57M Buy
54,647
+14,358
+36% +$2.2M 0.23% 67
2023
Q3
$6.28M Sell
40,289
-327
-0.8% -$54K 0.22% 66
2023
Q2
$6.72M Sell
40,616
-1,643
-4% -$265K 0.23% 63
2023
Q1
$6.55M Buy
42,259
+30,722
+266% +$4.96M 0.23% 69
2022
Q4
$2.04M Buy
11,537
+1,687
+17% +$291K 0.1% 61
2022
Q3
$1.61M Sell
9,850
-650
-6% -$110K 0.09% 61
2022
Q2
$1.86M Buy
10,500
+108
+1% +$19.2K 0.1% 59
2022
Q1
$1.84M Buy
10,392
+146
+1% +$24.8K 0.09% 64
2021
Q4
$1.75M Sell
10,246
-508
-5% -$83.2K 0.09% 64
2021
Q3
$1.74M Buy
10,754
+978
+10% +$167K 0.09% 62
2021
Q2
$1.61M Buy
9,776
+2,352
+32% +$389K 0.09% 64
2021
Q1
$1.22M Sell
7,424
-166
-2% -$26.9K 0.08% 71
2020
Q4
$1.19M Sell
7,590
-898
-11% -$133K 0.08% 65
2020
Q3
$1.26M Sell
8,488
-1,658
-16% -$245K 0.11% 62
2020
Q2
$1.43M Buy
10,146
+680
+7% +$99.1K 0.14% 55
2020
Q1
$1.24M Sell
9,466
-618
-6% -$87.7K 0.15% 57
2019
Q4
$1.47M Buy
10,084
+1,196
+13% +$162K 0.15% 64
2019
Q3
$1.15M Sell
8,888
-2,265
-20% -$298K 0.13% 73
2019
Q2
$1.55M Sell
11,153
-170
-2% -$23.5K 0.18% 54
2019
Q1
$1.58M Buy
11,323
+1,636
+17% +$219K 0.19% 52
2018
Q4
$1.25M Sell
9,687
-1,922
-17% -$268K 0.18% 61
2018
Q3
$1.6M Sell
11,609
-4,521
-28% -$601K 0.21% 58
2018
Q2
$1.96M Sell
16,130
-6,669
-29% -$832K 0.26% 55
2018
Q1
$2.92M Sell
22,799
-21
-0.1% -$2.84K 0.35% 44
2017
Q4
$3.19M Buy
22,820
+1,457
+7% +$203K 0.39% 45
2017
Q3
$2.78M Buy
21,363
+985
+5% +$131K 0.36% 46
2017
Q2
$2.7M Buy
20,378
+346
+2% +$44.1K 0.38% 44
2017
Q1
$2.5M Buy
20,032
+720
+4% +$86K 0.36% 51
2016
Q4
$2.23M Sell
19,312
-720
-4% -$83.2K 0.35% 55
2016
Q3
$2.37M Buy
20,032
+3,599
+22% +$437K 0.41% 45
2016
Q2
$1.99M Buy
16,433
+3,231
+24% +$367K 0.38% 45
2016
Q1
$1.43M Buy
13,202
+2,631
+25% +$272K 0.29% 49
2015
Q4
$1.09M Buy
10,571
+870
+9% +$87.5K 0.26% 47
2015
Q3
$906K Buy
9,701
+91
+0.9% +$8.8K 0.24% 50
2015
Q2
$937K Buy
9,610
+403
+4% +$40.4K 0.23% 50
2015
Q1
$926K Sell
9,207
-1,784
-16% -$181K 0.24% 52
2014
Q4
$1.15M Buy
10,991
+1,035
+10% +$109K 0.31% 46
2014
Q3
$1.06M Buy
9,956
+313
+3% +$32.5K 0.31% 46
2014
Q2
$1.01M Sell
9,643
-1,282
-12% -$130K 0.29% 49
2014
Q1
$1.07M Buy
+10,925
New +$1.01M 0.32% 42

Other funds holding JNJ

Choreo LLC's JNJ Position: Q1 2026 in Review

Choreo LLC increased its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, buying an estimated $738K and bringing the position to 142,648 shares worth $34.9M. The position accounts for 0.43% of the portfolio, ranked #45.

Choreo LLC first reported a position in JNJ in Q1 2014 and has held it in 49 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Choreo LLC held 142,648 shares of Johnson & Johnson worth $34.9M as of Q1 2026.
  • Choreo LLC bought 3,169 Johnson & Johnson shares in Q1 2026, an estimated $738K.
  • Johnson & Johnson made up 0.43% of Choreo LLC's portfolio in Q1 2026, its #45 holding.
  • Choreo LLC first reported a position in Johnson & Johnson in Q1 2014 and has held it in 49 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.